Does Veozah Cause Liver Problems? Understanding the FDA Warning
•
3 min read
In December 2024, the U.S. Food and Drug Administration (FDA) added a Boxed Warning to the prescribing information for Veozah (fezolinetant) regarding the risk of serious liver injury. This warning was issued after a postmarketing case highlighted a rare but potentially serious hepatotoxicity event. It is crucial for patients and healthcare providers to understand that **does veozah cause liver problems** in rare instances, necessitating careful monitoring.